ArticleFrontiers in pharmacology2018

A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation.

Carolina Pellegrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.